Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trialFang Liu, Jingping Zhao, Xiaofeng Guo et al.|Schizophrenia Research|2014Cited by 136
Changes in plasma levels of nitric oxide metabolites and negative symptoms after 16-week minocycline treatment in patients with schizophreniaFang Liu, Xiaoduo Fan, Jingping Zhao et al.|Schizophrenia Research|2018Cited by 19
PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patientsJing Huang, Renrong Wu, Xiaoyi Wang et al.|Psychopharmacology|2022Cited by 16